Wiley Bros. Aintree Capital, LLC Viatris Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 160,610 shares of VTRS stock, worth $1.67 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
160,610
Previous 84,044
91.1%
Holding current value
$1.67 Million
Previous $732,000
95.9%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding VTRS
# of Institutions
1,140Shares Held
973MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.51 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$963 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$818 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$690 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$574 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...